Vol 3 Issue 4

CELL AND GENE THERAPY INSIGHTS

April 2017 Issue

Vol 3 Issue 4

Download PDF

Featuring

Issue Spotlight: Latest Developments in CAR-T Cell Manufacturing
Other articles
Webinar

SPOTLIGHT

Latest Developments in CAR-T Cell Manufacturing
Isabelle Riviere
Guest Editor:
Isabelle Riviere, , Vice President, Head of Oncology Cell Therapy Technologies and Product Engine at Takeda

Expert Insight

Toward an integrated model of product characterization for CAR-T cell therapy drug development efforts

Toward an integrated model of product characterization for CAR-T cell therapy drug development efforts

Sadik Kassim
5 May 2017
Read
The regulation of CAR-T cells

The regulation of CAR-T cells

Shirley Bartido
5 May 2017
Read

Innovator Insight

How short-term gain can lead to long-term pain

How short-term gain can lead to long-term pain

David James
14 August 2017
Read

Interview

Progress and challenges in the manufacturing of CAR-T cell therapy

Progress and challenges in the manufacturing of CAR-T cell therapy

Bruce Levine
5 May 2017
Read
Challenges & opportunities for manufacturing autologous cellular therapies such as CAR-T cells

Challenges & opportunities for manufacturing autologous cellular therapies such as CAR-T cells

Dawn Maier
5 May 2017
Read
Goals behind NCI’s T cell manufacturing supplement grant awards

Goals behind NCI’s T cell manufacturing supplement grant awards

Anthony Welch
5 May 2017
Read

Journal articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – May 2017

Cell & Gene Therapy Commercial Insight – May 2017

12 June 2017
Read
Cell & Gene Therapy Commercial Insight – March 2017

Cell & Gene Therapy Commercial Insight – March 2017

Mark Curtis, Richard Philipson
2 May 2017
Read

Webinars